ArticleSleep & breathing = Schlaf & Atmung2026
Identifying patients at risk for jaw pain during oral appliance therapy for obstructive sleep apnea: clinical and craniofacial risk factors from a consecutive cohort.
Article in Sleep & breathing = Schlaf & Atmung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeOral appliance therapy (OAT) is an established treatment for obstructive sleep apnea (OSA). Temporomandibular disorder (TMD) symptoms, particularly jaw pain, are frequent side effects that may reduce adherence. This study evaluated clinical, behavioral, and craniofacial risk factors for OAT-related jaw pain as a symptom of TMD.
methodsWe retrospectively reviewed charts of 595 adults with OSA referred for OAT at Mayo Clinic, Rochester (Jan 2021-Sep 2023). Demographics, comorbidities, parafunctional habits, TMD symptoms, and craniofacial measurements were collected. Inclusion required OSA diagnosis, OAT initiation, at least one follow-up visit, and research consent.
resultsMedian age was 58 years, BMI 31, and AHI 11/h; 53% were male. At baseline, 11% reported jaw pain. Post-OAT TMD-related jaw pain was more common in patients with headache, fibromyalgia, pre-OAT pain, jaw noises, limited opening, clenching/grinding, and masseter or temporalis tenderness (all p < 0.05). Craniofacial features including mandibular retrusion and Class II Division I malocclusion were significantly associated with post-OAT pain.
conclusionIn this exploratory study, post-OAT TMD-related jaw pain was associated with pre-existing TMD symptoms (e.g., pain, joint noises, muscle tenderness), systemic comorbidities (headache, fibromyalgia), parafunctional behaviors, and craniofacial features such as mandibular retrusion and Class II Division I malocclusion. Recognition of these factors may help clinicians identify higher-risk patients and guide monitoring strategies to support sustained OAT adherence.
Indexed as
Identifiers
42541629What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.